InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
T+90 hit rate
8%
T+90 mean return
-16.5%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Febbo Phillip G., Chief Scientific & Med Officer. Insider active across 2 companies, notably Veracyte, INC.. In total, 19 filings have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €1m. History available since 11 June 2021. The latest transaction was filed on 6 October 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations19 total
8,349 shares@ US$36.017450.0% of flowCommon StockSEC:0001649245-25-000005
8,349 shares@ US$36.01740.0084% mcap50.0% of flowCommon StockSEC:0001649245-25-000005:0
24,160 shares0Common StockSEC:0001384101-25-000044:0
4,467 shares@ US$32.864912.7% of flowCommon StockSEC:0001384101-25-000032:0
30,589 shares0Common StockSEC:0001384101-25-000024:0
3,934 shares@ US$44.089315.0% of flowCommon StockSEC:0001384101-24-000186:0
6,738 shares@ US$44.1225.6% of flowCommon StockSEC:0001384101-24-000179:0
39,904 shares0Common StockSEC:0001384101-24-000036:0
53,182 shares0Common StockSEC:0001384101-23-000155:0
7,556 shares0Common StockSEC:0001127602-23-008575:0
3,522 shares0Common StockSEC:0001127602-23-006823:0
821 shares@ US$217.1923.8% of flowCommon StockSEC:0001127602-22-025123:0
131 shares@ US$363.840.0002% mcap7.5% of flowCommon StockSEC:0001127602-22-011725:0
3,029 shares0Common StockSEC:0001127602-22-008112:0
2,851 shares0Common StockSEC:0001127602-22-006616:0
446 shares@ US$408.140.0007% mcap26.9% of flowCommon StockSEC:0001127602-21-028723:0
446 shares@ US$408.140.0007% mcap58.1% of flowCommon StockSEC:0001127602-21-028723
310 shares@ US$446.1714.8% of flowCommon StockSEC:0001127602-21-019827
310 shares@ US$446.170.0005% mcap19.4% of flowCommon StockSEC:0001127602-21-019827:0
19 of 19 declarations
About Febbo Phillip G.
Phillip G. Febbo is the Chief Scientific and Medical Officer at VERACYTE, INC. and ILLUMINA, INC. He oversees the scientific and medical initiatives of the companies, contributing to innovation in the biotechnology field. His expertise is essential for developing new solutions.
